BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20934562)

  • 1. Hormone replacement therapy among postmenopausal women presenting with acute myocardial infarction: insights from the GUSTO-III trial.
    Tackett AH; Bailey AL; Foody JM; Miller JM; Apperson-Hansen C; Ohman EM; Hochman JS; Karnash SL; Califf RM; Topol EJ; Moliterno DJ
    Am Heart J; 2010 Oct; 160(4):678-84. PubMed ID: 20934562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmenopausal hormone use in women with acute coronary syndromes.
    Parsons E; Newby LK; Bhapkar MV; Alexander KP; White HD; Shah SH; Bushnell CD; Califf RM;
    J Womens Health (Larchmt); 2004 Oct; 13(8):863-71. PubMed ID: 15671702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I.
    Kaul P; Armstrong PW; Chang WC; Naylor CD; Granger CB; Lee KL; Peterson ED; Califf RM; Topol EJ; Mark DB
    Circulation; 2004 Sep; 110(13):1754-60. PubMed ID: 15381645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy and cardiovascular health in the United States.
    Shetty KD; Vogt WB; Bhattacharya J
    Med Care; 2009 May; 47(5):600-6. PubMed ID: 19319001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial.
    Simes RJ; O'Connell RL; Aylward PE; Varshavsky S; Diaz R; Wilcox RG; Armstrong PW; Granger CB; French JK; Van de Werf F; Marschner IC; Califf R; White HD;
    Am Heart J; 2010 Jun; 159(6):988-97. PubMed ID: 20569711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy.
    Schuetz F; Diel IJ; Pueschel M; von Holst T; Solomayer EF; Lange S; Sinn P; Bastert G; Sohn C
    Am J Obstet Gynecol; 2007 Apr; 196(4):342.e1-9. PubMed ID: 17403414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial.
    Schierbeck LL; Rejnmark L; Tofteng CL; Stilgren L; Eiken P; Mosekilde L; Køber L; Jensen JE
    BMJ; 2012 Oct; 345():e6409. PubMed ID: 23048011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial blood flow and flow reserve in response to short-term cyclical hormone replacement therapy in postmenopausal women.
    Duvernoy CS; Rattenhuber J; Seifert-Klauss V; Bengel F; Meyer C; Schwaiger M
    J Gend Specif Med; 2001; 4(3):21-7, 47. PubMed ID: 11605352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of androgen receptor gene polymorphism to bone mineral density and fracture risk in early postmenopausal women during a 5-year randomized hormone replacement therapy trial.
    Salmén T; Heikkinen AM; Mahonen A; Kröger H; Komulainen M; Pallonen H; Saarikoski S; Honkanen R; Mäenpää PH
    J Bone Miner Res; 2003 Feb; 18(2):319-24. PubMed ID: 12568409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Stramba-Badiale M
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy and secondary cardiovascular prevention: a meta-analysis of randomized trials.
    Cho L; Mukherjee D
    Cardiology; 2005; 104(3):143-7. PubMed ID: 16118493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there evidence of implicit exclusion criteria for elderly subjects in randomized trials? Evidence from the GUSTO-1 study.
    Krumholz HM; Gross CP; Peterson ED; Barron HV; Radford MJ; Parsons LS; Every NR
    Am Heart J; 2003 Nov; 146(5):839-47. PubMed ID: 14597933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hormone replacement therapy on hemostatic variables in post-menopausal women.
    Al-Farra HM; Al-Fahoum SK; Tabbaa MA
    Saudi Med J; 2005 Dec; 26(12):1930-5. PubMed ID: 16380775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy and arterial blood pressure in postmenopausal women with hypertension.
    Karalis I; Beevers G; Beevers M; Lip G
    Blood Press; 2005; 14(1):38-44. PubMed ID: 15823946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy use and menopausal symptoms among women participating in a behavioral lifestyle intervention.
    Boraz MA; Simkin-Silverman LR; Wing RR; Meilahn EN; Kuller LH
    Prev Med; 2001 Aug; 33(2 Pt 1):108-14. PubMed ID: 11493043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long-term impact of 2-3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women.
    Alexandersen P; Tankó LB; Bagger YZ; Qin G; Christiansen C
    Climacteric; 2006 Apr; 9(2):108-18. PubMed ID: 16698657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of hormone replacement therapy and resistance training on spine bone mineral density in early postmenopausal women.
    Maddalozzo GF; Widrick JJ; Cardinal BJ; Winters-Stone KM; Hoffman MA; Snow CM
    Bone; 2007 May; 40(5):1244-51. PubMed ID: 17291843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolytic therapy use for acute myocardial infarction and outcome in Qatar.
    Hadi HA; Al Suwaidi J; Bener A; Khinji A; Al Binali HA
    Int J Cardiol; 2005 Jul; 102(2):249-54. PubMed ID: 15982492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative.
    Gehrie ER; Reynolds HR; Chen AY; Neelon BH; Roe MT; Gibler WB; Ohman EM; Newby LK; Peterson ED; Hochman JS
    Am Heart J; 2009 Oct; 158(4):688-94. PubMed ID: 19781432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy and risk of nonfatal acute myocardial infarction in Italy.
    Tavani A; Bertuzzi M; Gallus S; Negri E; La Vecchia C
    J Clin Epidemiol; 2005 Jul; 58(7):747-50. PubMed ID: 15939229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.